New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
Standard
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. / Stroncek, David F; Berger, Carolina; Cheever, Martin A; Childs, Richard W; Dudley, Mark E; Flynn, Peter; Gattinoni, Luca; Heath, James R; Kalos, Michael; Marincola, Francesco M; Miller, Jeffrey S; Mostoslavsky, Gustavo; Powell, Daniel J; Rao, Mahendra; Restifo, Nicholas P; Rosenberg, Steven A; O'Shea, John; Melief, Cornelis J M.
in: J TRANSL MED, Jahrgang 10, 15.03.2012, S. 48.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
AU - Stroncek, David F
AU - Berger, Carolina
AU - Cheever, Martin A
AU - Childs, Richard W
AU - Dudley, Mark E
AU - Flynn, Peter
AU - Gattinoni, Luca
AU - Heath, James R
AU - Kalos, Michael
AU - Marincola, Francesco M
AU - Miller, Jeffrey S
AU - Mostoslavsky, Gustavo
AU - Powell, Daniel J
AU - Rao, Mahendra
AU - Restifo, Nicholas P
AU - Rosenberg, Steven A
AU - O'Shea, John
AU - Melief, Cornelis J M
PY - 2012/3/15
Y1 - 2012/3/15
N2 - A summit on cellular therapy for cancer discussed and presented advances related to the use of adoptive cellular therapy for melanoma and other cancers. The summit revealed that this field is advancing rapidly. Conventional cellular therapies, such as tumor infiltrating lymphocytes (TIL), are becoming more effective and more available. Gene therapy is becoming an important tool in adoptive cell therapy. Lymphocytes are being engineered to express high affinity T cell receptors (TCRs), chimeric antibody-T cell receptors (CARs) and cytokines. T cell subsets with more naïve and stem cell-like characteristics have been shown in pre-clinical models to be more effective than unselected populations and it is now possible to reprogram T cells and to produce T cells with stem cell characteristics. In the future, combinations of adoptive transfer of T cells and specific vaccination against the cognate antigen can be envisaged to further enhance the effectiveness of these therapies.
AB - A summit on cellular therapy for cancer discussed and presented advances related to the use of adoptive cellular therapy for melanoma and other cancers. The summit revealed that this field is advancing rapidly. Conventional cellular therapies, such as tumor infiltrating lymphocytes (TIL), are becoming more effective and more available. Gene therapy is becoming an important tool in adoptive cell therapy. Lymphocytes are being engineered to express high affinity T cell receptors (TCRs), chimeric antibody-T cell receptors (CARs) and cytokines. T cell subsets with more naïve and stem cell-like characteristics have been shown in pre-clinical models to be more effective than unselected populations and it is now possible to reprogram T cells and to produce T cells with stem cell characteristics. In the future, combinations of adoptive transfer of T cells and specific vaccination against the cognate antigen can be envisaged to further enhance the effectiveness of these therapies.
KW - Cell Transplantation/methods
KW - Humans
KW - Immunotherapy, Adoptive
KW - Lymphocytes, Tumor-Infiltrating/immunology
KW - Melanoma/therapy
KW - Neoplasms/therapy
U2 - 10.1186/1479-5876-10-48
DO - 10.1186/1479-5876-10-48
M3 - SCORING: Journal article
C2 - 22420641
VL - 10
SP - 48
JO - J TRANSL MED
JF - J TRANSL MED
SN - 1479-5876
ER -